TORONTO–(BUSINESS WIRE)–The More Life Company Corp. (the “Company” or “MLCO”), (CSE: MLCO) (OTC: TMLCF) is pleased to announce that it has entered into a strategic letter of intent (“LOI”) with an established U.S. 503A compounding pharmacy to advance the development, compounding and commercialization of Quicksome™-enabled prescription compounded pharmaceutical products in the United States. The contemplated relationship is designed to establish dedicated U.S. compounding capability for Quicks